Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for ...
Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab.
(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors How Much Is The ...
Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa ...
Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics. Mechanical stress testing is essential because ...
Sept 19 (Reuters) - The European Medicines Agency's committee has recommended approval for a new formulation of Merck's (MRK.N), opens new tab blockbuster cancer therapy Keytruda that can be ...
Process liquids and buffers are necessary tools for biotherapeutic manufacturing. In small-scale process development scales, these liquids are often overlooked as the focus is usually on the molecule, ...
The US Department of Health and Human Services has adopted a recommendation to remove thimerosal from all influenza vaccines distributed in the United States, even though there is no clear evidence of ...
Please provide your email address to receive an email when new articles are posted on . The original formulation of Shingrix consists of two separate vials combined by health care workers prior to ...
Custom plastic injection molding with in-house tool & die Buffer and reagent formulation, filling, and labeling OEM and private label kitting Full-package assembly, inspection, and global distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results